Elizabeth Lehinger

Dr. Elizabeth Lehinger

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2022 in Addictive Behaviors
Verified
Journal Article
Closed access
ELElizabeth Lehinger
Elizabeth Lehinger
SGScott Graupensperger
Scott Graupensperger
FSFrank Song
Frank Song
BHBrittney A. Hultgren
Brittney A. Hultgren
DJDara Jackson
Dara Jackson
MLMary E. Larimer
Mary E. Larimer

23 August 2022 in Journal of Traumatic Stress
Verified
Journal Article
Closed access
ELElizabeth Lehinger
Elizabeth Lehinger
MBMichele Bedard‐Gilligan
Michele Bedard‐Gilligan
AHAsh Holloway
Ash Holloway
DKDebra Kaysen
Debra Kaysen

10 July 2025 in Addiction
Verified
Journal Article
Open access
DHDenise Hien
Denise Hien
JGJordan Gette
Jordan Gette
SBShannon M. Blakey
Shannon M. Blakey
MPMarilyn L. Piccirillo
Marilyn L. Piccirillo
SBSudie E. Back
Sudie E. Back
AMAntonio A. Morgan‐López
Antonio A. Morgan‐López
Background and Aims: Post‐traumatic stress disorder (PTSD) commonly co‐occurs with substance use disorders (SUD). Comorbid PTSD and SUD (PTSD+SUD) is associated with greater severity and impairment and poorer treatment outcomes. Several interventions exist to treat PTSD, SUD and PTSD+SUD; however, research has yet to elucidate the indirect pathways underlying treatment for PTSD+SUD. The present study examined how changes in PTSD severity relate to changes in SUD severity across treatment types during and post‐treatment.Methods: Observational study using data collected as part of Project Harmony, a virtual clinical trial employing integrative data analysis to compare treatment effectiveness of PTSD+SUD interventions from 36 randomized controlled trials for PTSD+SUD (n = 4046). Multilevel mediated linear growth modeling was used to examine potential outcomes mediation. Each of the eight active treatments was compared to treatment as usual (TAU) for both alcohol and drug use outcomes.Results: Alcohol use severity outcomes were fully or partially mediated by changes in PTSD severity for trauma‐focused psychotherapy + AUD medication [ab = −0.16 (95% confidence interval = −0.30 to −0.04)]; other treatments with mediation effects included trauma‐focused integrated psychotherapy, AUD medications and PTSD medications. Drug use severity outcomes were fully or partially mediated by changes in PTSD severity for trauma‐focused psychotherapy + AUD medication [ab = −0.08 (−0.18 to −0.001)]; other treatments with mediation effects on drug use severity included trauma‐focused integrated psychotherapy, AUD medications, PTSD medications and placebo medications.Conclusions: Among people with co‐occurring post‐traumatic stress disorder (PTSD) and substance use disorders (SUD), reductions in alcohol and drug use severity appear to be mediated by reductions in PTSD during treatment. For those with drug use disorders, PTSD reductions appear to mediate further SUD reductions after treatment.

25 June 2023 in Journal of Mood & Anxiety Disorders
Verified
Journal Article
Open access
PRPeter L. Rosencrans
Peter L. Rosencrans
NGNatalia M. Garcia
Natalia M. Garcia
ACAndrew A. Cooper
Andrew A. Cooper
ELElizabeth Lehinger
Elizabeth Lehinger
JBJenna Bagley
Jenna Bagley
LZLori A. Zoellner
Lori A. Zoellner
In developing personalized care for PTSD, baseline predictors that inform clinicians' and patients' decision making across treatment options are limited. In 200 individuals with PTSD in a multi-site, doubly randomized preference trial, baseline psychopathology, personality/mood regulation, health/social functioning, treatment credibility and history, and demographic factors predicted PTSD severity from baseline, ten sessions, to post-treatment. Using a stepwise prognostic and prescriptive modeling approach, rates of change and post-treatment outcomes between prolonged exposure [PE] vs sertraline and preferred vs non-preferred treatments were examined. Stronger credibility of PE predicted faster improvement (b = −0.28, SE = 0.10) and lower post-treatment scores (b = −2.40, SE = 1.08). Higher avoidance predicted poorer outcomes for those who did not receive their preferred treatment (b = −5.33, SE = 2.42). Similarly, being psychiatric medication naïve predicted poorer response for those who did not receive their preferred treatment (b = −13.03, SE = 5.71). Across a range of baseline predictors, stronger credibility of PE, potentially reflecting the patient's perceived need to actively discuss and process the trauma memory, emerged as one of the best predictors of PTSD treatment outcome. Particular attention should be paid to matching more avoidant and medication-naïve patients to their preferred treatment. All data, program code, and other methods developed by others have been cited appropriately in text. The dataset for this study comes from a previously published clinical trial [NCT00127673, 29] and is available by request by competent researchers. Computer syntax used for this study is available upon request. Research materials, including treatment rationales and manuals, are available upon request.

24 June 2022 in Journal of Clinical Psychology in Medical Settings
Verified
Journal Article
Closed access
PDF file
ELElizabeth Lehinger
Elizabeth Lehinger
DRDavid E. Reed
David E. Reed
DMDonald D. McGeary
Donald D. McGeary
BHBrittany N. Hager
Brittany N. Hager
JRJohn D. Roache
John D. Roache

26 June 2025 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
ELElizabeth Lehinger
Elizabeth Lehinger
MJMolly Joseph
Molly Joseph
ALAntoine Lebeaut
Antoine Lebeaut
SGScott Graupensperger
Scott Graupensperger
DKDebra Kaysen
Debra Kaysen
MBMichele A Bedard-Gilligan
Michele A Bedard-Gilligan
Trauma cognitions have been widely supported as a mechanism of change in post-traumatic stress disorder (PTSD) treatment. Less is known about the mediating role of trauma cognitions in early interventions addressing PTSD symptoms and co-occurring conditions such as alcohol misuse. This study was a secondary analysis of data collected as part of a pilot randomized clinical trial of a single session intervention and four coaching calls (BRITE), adapted from Cognitive Processing Therapy for survivors of a sexual assault that occurred in the past 10 weeks. Fifty-seven adult female-identifying individuals with symptoms of PTSD and alcohol misuse randomized to either intervention or symptom monitoring completed the assessments of PTSD severity, alcohol use, and trauma cognitions at intake, post-intervention, and 3-month follow-up. Mixed-effects models showed trauma cognitions improved significantly in the BRITE condition but did not change in the symptom monitoring condition (b = −1.53, p < 0.001, B = −1.05). Mediation analyses indicated that change in total trauma cognitions and self-blame cognitions did not have a significant indirect effect on the association between condition and PTSD symptoms and average drinks on drinking days, and the proportion mediated was small for PTSD symptoms and average drinks. Preliminary findings indicate reductions in negative trauma cognitions for the BRITE condition, but this is likely one of several factors that play a role in changes in PTSD symptoms and alcohol use in the early recovery period following sexual assault.